Consuming too much salt has long been recognized as a primary threat to cardiovascular wellness, heavily linked to hypertension and widespread public health concerns. However, a growing body of scientific evidence suggests that the consequences of an excessive sodium intake extend far beyond elevated blood pressure. Recent studies indicate that high-salt diets may systematically interfere with core cognitive functions, disrupting memory, altering thinking processes, and negatively impacting emotional well-being. These profound neurological risks have made the search for protective strategies and dietary interventions increasingly urgent for researchers worldwide.
Addressing this critical health challenge, a team of researchers in Japan has identified a promising therapeutic candidate in LPC70, a specialized compound derived from soybeans. While earlier scientific investigations demonstrated that this unique ingredient could successfully mitigate high-pressure cardiovascular issues and cognitive declines associated with high-salt consumption in laboratory models, the exact biological mechanisms remained elusive. A comprehensive new study has taken a much deeper look into how the compound operates, revealing that it exerts precise, highly regulated chemical influences across both the brain and the kidneys.
How a Soy Compound May Counter the Effects of Excess Salt
At the core of the new research is an intricate look at prostaglandins, which are powerful signaling molecules generated from arachidonic acid, a vital fatty acid found throughout the body. These chemical substances function in a manner very similar to local hormones, playing indispensable roles in regulating critical physiological functions across multiple organ systems.
Within the cardiovascular network, prostaglandins are instrumental in managing blood pressure by delicately balancing the constriction and dilation of blood vessels. Their regulatory functions within the central nervous system, however, are significantly more complex. Depending entirely upon which specific cellular receptors they activate, these signaling molecules can trigger cascades that either protect delicate nerve cells from harm or contribute to damaging inflammatory processes. These downstream effects can ultimately impair memory formation, cognitive flexibility, and emotional regulation.
LPC70 is a specialized form of soy lysolecithin in which lysophosphatidylcholine accounts for more than 70 percent of the total phospholipid content. Although earlier trials confirmed that LPC70 could successfully ease salt-induced hypertension and cognitive difficulties in experimental settings, scientists previously lacked a comprehensive understanding of the precise molecular pathways responsible for these benefits, particularly regarding prostaglandin signaling dynamics.
To bridge this crucial knowledge gap, a dedicated research team led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close collaboration with Dr. Kazuhiro Kagotani, set out to examine how LPC70 specifically alters these vital signaling pathways in subjects maintained on a high-salt diet.
Dr. Kubota, who served as the study’s first author, was instrumental in executing the rigorous experimental design. He systematically evaluated blood pressure fluctuations, observed subtle behavioral adaptations, and quantified molecular activity tied directly to prostaglandin pathways. His detailed analytical work helped clarify how LPC70 is able to generate differential, organ-specific protective effects in the exact biological tissues most vulnerable to salt-related damage.
The academic leadership behind the project includes Prof. Mouri and Dr. Kubota, both affiliated with the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, alongside the International Center for Brain Science at Fujita Health University. Meanwhile, Dr. Kagotani contributes expertise from Tsuji Oil Mills Co., Ltd., and the Tsuji Health and Beauty Science Laboratory at Mie University.
The findings resulting from this extensive collaboration were released online on May 14, 2026, and subsequently published in Volume 197 of the academic journal Neurochemistry International on July 1, 2026.
"We wanted to understand the role of LPC70 in coordinating changes in prostaglandin signaling across organ systems," explained Prof. Mouri, discussing the origins of the project. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd., a company that develops naturally derived food ingredients," he added.
Soy Compound Improves Blood Pressure and Memory in Mice
To test the efficacy of the soy-derived compound, the researchers evaluated laboratory mice subjected to a high-salt diet. As expected, the animals quickly developed elevated blood pressure, confirming the immediate cardiovascular toll of excessive sodium intake. However, thorough behavioral and physiological monitoring revealed that the pathological consequences extended far beyond cardiovascular strain.
The animals subjected to high salt levels also exhibited notable changes in social behavior, becoming significantly less interactive with their peers. Furthermore, they demonstrated marked difficulties in recognizing familiar objects they had encountered previously, pointing directly to underlying deficits in recognition memory.
Interestingly, other general parameters—such as baseline physical movement and anxiety-like behaviors—showed no substantial alterations. This distinct behavioral pattern suggests that excessive salt intake selectively targets and disrupts more complex cognitive and social processing functions rather than causing generalized physical or widespread behavioral impairment across the board.
When the research team supplemented the high-salt diets of the test subjects with LPC70, a striking reversal of several adverse effects was observed. Not only did the animals’ blood pressure readings improve toward healthier baselines, but the mice also demonstrated significantly enhanced performance during standardized tests measuring social interaction and object recognition memory.
These promising functional improvements prompted the investigators to look deeper into the biological tissue to determine precisely what changes were occurring at the molecular level inside the animals’ kidneys and brains.
Different Protective Effects in the Kidneys and Brain
Upon examining renal tissue, the scientists discovered that a high-salt diet significantly increased the expression of two key molecular components involved in prostaglandin synthesis and signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these biological factors are strongly implicated in driving the development of salt-sensitive hypertension.
When LPC70 was introduced into the dietary regimen, it effectively suppressed these salt-related increases. This indicated that the soy compound helps correct harmful signaling alterations in the kidneys that would otherwise interfere with the body’s ability to properly regulate systemic blood pressure.
In the prefrontal cortex—a critical brain region responsible for higher-order thinking, memory retention, and social interaction—the research team uncovered a completely different pattern of response.
Excessive dietary salt led to a reduction in the expression of the PGD2 receptor known as DP1, which normally plays a protective, anti-inflammatory role within the central nervous system. Remarkably, treatment with LPC70 successfully restored the expression levels of this beneficial receptor without altering DP2, a secondary receptor associated with potentially neurotoxic or harmful nerve cell signaling.
This clear distinction is exceptionally important from a pharmacological and nutritional standpoint. It demonstrates that LPC70 does not act as a blunt instrument that merely amplifies or suppresses all prostaglandin activity indiscriminately. Instead, it selectively favors signaling pathways that help shield the brain from injury, offering a plausible molecular explanation for the cognitive and social recoveries observed in the experimental subjects.
A Surprising Change in Chemical Signaling
Beyond tracking individual receptor populations, the research team stumbled upon an unexpected biochemical shift involving arachidonic acid, the foundational fatty acid utilized by the mammalian body to synthesize various prostaglandins.
Mice consuming excessive amounts of salt exhibited notably lower levels of circulating arachidonic acid. Yet, when these same animals received the LPC70 supplement, the downstream production of specific prostaglandins derived from this fatty acid—including both PGE2 and PGD2—actually increased.
This seemingly contradictory result provides vital clues regarding the compound’s mode of action. It suggests that LPC70 may optimize metabolic efficiency, enabling the body to utilize available stores of arachidonic acid more effectively for protective prostaglandin synthesis even under high-salt physiological stress.
Taken as a whole, the data reveals a highly coordinated yet remarkably selective biological response. Within the kidneys, LPC70 appears to downregulate signaling shifts directly tied to hypertension. Simultaneously, within the central nervous system, it restores protective signaling pathways dedicated to fighting inflammation and cellular damage. Consequently, the compound’s ultimate therapeutic impact relies heavily upon the specific organ involved and the distinct subset of prostaglandin receptors being modulated.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The compelling nature of these results raises the distinct possibility that LPC70 could eventually be developed into a specialized functional food ingredient designed to help mitigate some of the severe physiological consequences linked to high daily sodium consumption.
Its demonstrated capacity to jointly improve systemic blood pressure and preserve cognitive performance in animal models points toward an exciting future where dietary interventions might better support cardiovascular and neurological health, particularly among populations whose traditional or modern diets contain high amounts of sodium.
Nevertheless, researchers emphasize that these current findings are derived entirely from preclinical animal experiments. Comprehensive clinical trials involving human participants will be strictly necessary to confirm whether these exact protective benefits translate successfully to human physiology.
"Our study elucidates LPC70’s role in prostaglandin signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," concluded Prof. Mouri.
The research delivers a clearer picture of how a natural, soy-derived compound can fundamentally influence the way the body handles the physiological stress of excessive salt, opening up novel avenues for nutritional science in the protection of long-term human health.
The investigation received vital financial support through Grants-in-Aid for Scientific Research issued by the Japan Society for the Promotion of Science under designated reference numbers 20K07931, 22K07606, 22K11891, and 23H02843.
Additional backing was provided by the Fujita Mind-Brain Research and Innovation Center for Drug Generation through Japan’s Peak Research Universities Program under grant JPJS00420240019, alongside the Japan Science and Technology Agency FOREST Program via grant JPMJFR215H.
Direct research funding was also contributed by Tsuji Oil Mills Co., Ltd. Supplemental grants and institutional resources were further supplied by the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.